Florin Selaru’s research focuses on inflammation, fibrosis and cancer, specifically using bioengineering tools in drug and device development for inflammatory and malignant conditions, as well as tissue regeneration solutions. Specific projects include drug development for fibrosis in the gastrointestinal tract, microrobot development for oral drug delivery, tissue engineering for fistulas, and other tissue defects in inflammatory bowel disease (IBD), and novel drug targeting approaches for inflammation and cancer. Selaru’s overarching goal is to deliver medical products and technologies to patients with IBD and cancer.

Selaru has faculty appointments in the Division of Gastroenterology and Hepatology, the Johns Hopkins Kimmel Cancer Center, and the Department of Biomedical Engineering  He is a clinical expert in IBD and serves as the director of the Harvey M. and Lyn P. Meyerhoff Inflammatory Bowel Disease Center at Johns Hopkins. Selaru earned his medical degree at Carol Davila University of Medicine and Pharmacy in Bucharest, Romania. He completed his internal medicine residency at University of Maryland Medical Center in Baltimore and completed his fellowship training in gastroenterology and hepatology at the Johns Hopkins University School of Medicine.